# ALNY — AI stock forecast & analysis

> AI-generated analysis by K3vl4r — 2026-08-10. Informational only, not financial advice.

**Recommendation:** ACCUMULATE

**Scores (0–100):** Overall 5.5 · Fundamentals 7.5 · Technicals 4 · Growth 8.5 · Risk 6.5

## Summary

ALNY's fundamental strength from its TTR franchise and pipeline optionality remains intact despite recent repricing, but technicals show a broken base with significant downside risk to $197.81. The stock is currently trading at a deep discount to historical highs while facing elevated short interest and bearish analyst sentiment.

## Price targets (12-month horizon)

- Bear: $197.81
- Base: $235.00
- Bull: $315.00

## News context

Recent news highlights TTR franchise success ($1B+ quarterly revenue in Q2 2026) and pipeline progress, including Phase 3 trials for Nucresiran and Zilebesiran. However, Truist Financial cut its target to $315 from $410, signaling bearish sentiment. The stock is also facing competitive pressure from next-gen modalities like acoramidis, which could compress market share. While social sentiment is overwhelmingly bullish (100% bullish on StockTwits), the technicals and analyst consensus suggest a lack of near-term upside.

## About
- Methodology: https://app.k3vl4r.com/methodology
- Full report: https://app.k3vl4r.com/r/alny-ai-stock-forecast-a46b92eb799478c56498d69c5f85252a
- AI-generated; model outputs can be wrong. Not financial advice.